Pacliget 260mg Injection
Marketer
GLS Pharma Ltd.
Salt Composition
Paclitaxel (260mg)
Overview Pacliget 260mg Injection
Oncaspar 260mg injection is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administration is solely by a healthcare professional via injection. Dosage and frequency are determined by your physician, based on your specific condition and may adjust over time. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinue only under medical guidance. Typical side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (hand/lip swelling), alopecia (hair loss), and weight increase are also possible. Concomitant medications may be prescribed to mitigate these. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever to your doctor immediately. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests are crucial to monitor blood cell levels and liver function. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including antibiotics. Interactions with other drugs are possible; ensure complete medication disclosure to your physician. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is vital for both partners throughout treatment.
Primary Ingredients of Pacliget 260mg Injection
The provided text is "undefined," which cannot be rephrased. There is no text to rewrite.
Uses of Pacliget 260mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas
Major Benefits of Pacliget 260mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Pacliget 260mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Pacliget 260mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pacliget 260mg Injection works:
Oncaspar, a 260mg injectable anticancer agent, disrupts microtubule formation, a process essential for cancer cell division and proliferation. This disruption inhibits cancer growth, leading ultimately to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Pacliget 260mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Pacliget 260mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Medical advice is essential.
Breast feedingUNSAFE
Administering Pacliget 260mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The injectable medication Pacliget 260mg might induce adverse reactions that could impair driving ability. While driving isn't necessarily prohibited between treatments, the medication's alcohol content suggests caution behind the wheel.
KidneySAFE IF PRESCRIBED
Pacliget 260mg Injection poses no safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, consultation with a physician is advised if you have pre-existing kidney disease.
LiverCAUTION
Administering Pacliget 260mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Pacliget 260mg Injection might be necessary. Physician consultation is advised. Pacliget 260mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Pacliget 260mg Injection :
NA
Facts to Know About Pacliget 260mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Taxane Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently